Best GLP-1 Options for Fatty Liver Disease
Medical Disclaimer: Educational content only, not medical advice or endorsement. Verify current pricing, credentials and policies before enrolling. Full disclaimer. See our affiliate disclosure.
Fatty liver disease has gone from having almost no pharmacological options to having several, largely because GLP-1 medications turned out to improve the endpoints hepatologists care about most. This guide covers which agents have the strongest hepatic evidence and where the care needs to happen.
Top 5 GLP-1 Telehealth Providers 2026
Premium telehealth platform offering personalized GLP-1 weight loss programs with board-certified specialists and comprehensive support.
Pros:
- ✓ Board-certified endocrinology specialists
- ✓ Both FDA-approved and compounded options available
- ✓ Monthly lab monitoring included
- ✓ Dedicated care coordinator for each patient
- ✓ Same-day prescription approval in most cases
- ✓ Comprehensive weight loss support program
Cons:
- ✗ Higher cost tier for brand-name options
- ✗ Not available in all 50 states yet
Affordable compounded GLP-1 options with transparent pricing and straightforward telehealth consultations.
Pros:
- ✓ Very competitive pricing on compounded options
- ✓ Transparent flat-rate pricing
- ✓ Quick online consultation process
- ✓ Good customer service response times
Cons:
- ✗ Limited to compounded medications only
- ✗ Less personalized follow-up compared to top tier
- ✗ No dedicated care coordinator
Well-established telehealth platform with competitive pricing and wide availability across multiple health categories.
Pros:
- ✓ Strong brand reputation
- ✓ User-friendly platform and mobile app
- ✓ Bundled offerings with other health services
- ✓ Available in all 50 states
Cons:
- ✗ Generic consultation experience
- ✗ Limited specialist access
- ✗ Customer service can be slow during peak times
Comprehensive digital health platform offering GLP-1 medications alongside nutrition coaching and lifestyle support.
Pros:
- ✓ Holistic approach with coaching included
- ✓ Well-designed user interface
- ✓ Multiple medication options available
- ✓ Good educational resources
Cons:
- ✗ Higher price point than some competitors
- ✗ Coaching quality can vary
- ✗ Some users report slow prescription processing
Psychology-based weight loss program now offering GLP-1 medications with their signature behavioral coaching approach.
Pros:
- ✓ Strong behavioral psychology component
- ✓ Established weight loss program foundation
- ✓ Comprehensive app ecosystem
- ✓ Good for those who want structured program
Cons:
- ✗ More expensive overall due to program fees
- ✗ Complex pricing structure
- ✗ GLP-1 offering is newer, less refined
- ✗ Some users find app notifications excessive
Premium telehealth platform offering personalized GLP-1 weight loss programs with board-certified specialists and comprehensive support.
$99/mo starting
Pros
- ✓Board-certified endocrinology specialists
- ✓Both FDA-approved and compounded options available
- ✓Monthly lab monitoring included
- ✓Dedicated care coordinator for each patient
- ✓Same-day prescription approval in most cases
- ✓Comprehensive weight loss support program
Cons
- ✗Higher cost tier for brand-name options
- ✗Not available in all 50 states yet
Affordable compounded GLP-1 options with transparent pricing and straightforward telehealth consultations.
$297/month all-inclusive for compounded tirzepatide
Pros
- ✓Very competitive pricing on compounded options
- ✓Transparent flat-rate pricing
- ✓Quick online consultation process
- ✓Good customer service response times
Cons
- ✗Limited to compounded medications only
- ✗Less personalized follow-up compared to top tier
- ✗No dedicated care coordinator
Well-established telehealth platform with competitive pricing and wide availability across multiple health categories.
$199-$399/month depending on medication
Pros
- ✓Strong brand reputation
- ✓User-friendly platform and mobile app
- ✓Bundled offerings with other health services
- ✓Available in all 50 states
Cons
- ✗Generic consultation experience
- ✗Limited specialist access
- ✗Customer service can be slow during peak times
Comprehensive digital health platform offering GLP-1 medications alongside nutrition coaching and lifestyle support.
$145-$290/month for medication, plus $99 coaching fee
Pros
- ✓Holistic approach with coaching included
- ✓Well-designed user interface
- ✓Multiple medication options available
- ✓Good educational resources
Cons
- ✗Higher price point than some competitors
- ✗Coaching quality can vary
- ✗Some users report slow prescription processing
Psychology-based weight loss program now offering GLP-1 medications with their signature behavioral coaching approach.
$149/month for program + medication costs vary
Pros
- ✓Strong behavioral psychology component
- ✓Established weight loss program foundation
- ✓Comprehensive app ecosystem
- ✓Good for those who want structured program
Cons
- ✗More expensive overall due to program fees
- ✗Complex pricing structure
- ✗GLP-1 offering is newer, less refined
- ✗Some users find app notifications excessive
Top #1 Choice
CoreAge Rx
Our highest-rated provider for quality and value
Rankings based on quality, safety, efficacy, and cost considerations. See our affiliate disclosure for more information.
How We Assessed These
For liver disease the assessment weights hepatic evidence and specialist coordination over price.
| Criterion | What it means |
|---|---|
| Histologic evidence | Whether the agent has biopsy-confirmed fibrosis or MASH data |
| Hepatology coordination | Advanced fibrosis and cirrhosis need specialist management |
| Fibrosis monitoring | Whether staging is assessed and tracked |
| Comorbidity management | MASLD rarely travels alone |
| Agent selection | Dual agonists targeting glucagon show strong liver-fat effects |
What the Evidence Supports
Multiple meta-analyses find GLP-1 receptor agonists improve liver fibrosis, resolve steatohepatitis, and reduce liver enzymes in MASLD and MASH. A pooled analysis reported an odds ratio of 4.45 (95% CI 1.92-10.3) for resolution of MASH without worsening fibrosis. A 2026 analysis in JHEP Reports found GLP-1 receptor agonists superior to placebo for histologic improvement in fibrosis stage.
Trial reporting has described improvement in liver scarring and no progression of MASH in 37% of the GLP-1 group versus 22% of placebo. Researchers at UC San Diego reported semaglutide improved liver scarring in advanced MASH and early cirrhosis — a population with historically thin options.
Agents Targeting the Liver Directly
Some pipeline compounds treat hepatic endpoints as primary rather than incidental. Efinopegdutide (Merck) holds FDA Fast Track designation for NASH and reduced liver fat more than semaglutide over 24 weeks. Survodutide reported 34% visceral fat and 63% liver fat reduction with limited lean mass loss in Phase 3.
The pattern is the glucagon receptor — glucagon agonism increases hepatic fat oxidation, which is a plausible reason dual agonists show strong liver effects. None of these is approved yet.
Where This Care Belongs
If you have advanced fibrosis or cirrhosis, this is not a weight-loss telehealth decision. That population needs hepatology management and monitoring a general platform cannot provide.
For earlier-stage MASLD alongside obesity or type 2 diabetes, a GLP-1 prescribed through a competent provider is reasonable — but the liver findings should be shared with whoever manages your liver care, and fibrosis staging should be tracked rather than assumed to improve.
Questions Worth Asking Before You Enrol
- Has my fibrosis stage been assessed, and how will it be monitored?
- Do I need hepatology involvement given my staging?
- Which agent has the strongest hepatic evidence for my situation?
- Will liver enzymes and imaging be repeated?
- How does this coordinate with my other metabolic care?
A provider that answers these clearly is managing a treatment plan. One that deflects to a monthly price is selling a subscription.